Company profile
Vynleads, Inc.
OTC: VYND · Healthcare · Medical - Healthcare Information Services
#1166 of 1,422 Healthcare companies by revenue
EA Score
20DFH 6DQ 27GM 47SS 25
v0.1 · 65/100 weight · provisional
↑ growth stability, market scale · ↓ workforce scale, 3-yr revenue growth
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$255.1k
Employees
1
as of 2026-08-23
Market cap
$7.5M
as of 2026-08-23
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02025
Net income-$255.1k-$255.1k2025
Operating income-$247.3k-$247.3k2025
Total assets$53.7k$53.7k2025
Liabilities$406.1k$406.1k2025
Equity-$352.4k-$352.4k2025
Revenue trend
FY2019 – FY2025 · USD
FY19
FY19
FY20
FY21
FY22
FY24
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Vynleads, Inc.’s revenue?
Vynleads, Inc. booked $0 in FY2025 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
PreveCeutical Medical Inc.——Revive Therapeutics Ltd.——Unidoc Health Corp.——Modular Medical, Inc.34DExicure, Inc.31DSweet Earth Holdings Corporation22DNeighbors
York →Key facts
CEOAlex J. Mannine
SectorHealthcare
IndustryMedical - Healthcare Information Services
HeadquartersRock Hill, SC
ExchangeOTC: VYND
Employees1
IPO date2020-02-24
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.